Sapiens International (SPNS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Q3 2025 revenue grew 11.2% year-over-year to $152.3M, with double-digit expansion in North America and Rest of World.
Annualized recurring revenue (ARR) reached $219.7M, up 26.7% year-over-year, with 17.5% organic growth and 9.2% from acquisitions.
Non-GAAP operating profit was $25.5M, with a 16.7% margin; non-GAAP net income was $20.5M.
Announced definitive agreement to be acquired by Advent for $43.50 per share, valuing the company at $2.5B.
Financial highlights
GAAP net income attributable to shareholders was $14.3M, down from $18.3M in Q3 2024.
GAAP diluted EPS was $0.25, down 24.2% year-over-year; non-GAAP diluted EPS was $0.36, down 2.7%.
Adjusted EBITDA for Q3 2025 was $26.5M, nearly flat year-over-year.
Adjusted free cash flow was $9.5M, compared to $10.2M in Q3 2024.
Cash and cash equivalents at quarter-end were $82.2M, down from $163.7M at year-end 2024.
Outlook and guidance
Focus remains on advancing the insurance platform, accelerating cloud adoption, and expanding the global footprint.
Continued emphasis on AI-driven innovation and digital transformation for insurers.
Latest events from Sapiens International
- Revenue and ARR grew, but net income and margins declined amid acquisitions and a pending buyout.SPNS
Q2 202515 Mar 2026 - Growth driven by cloud transition, M&A, and recurring revenue, with SaaS headwinds easing by 2026.SPNS
27th Annual Needham Growth Conference3 Feb 2026 - Q2 2024 revenue up 6.6%, net income up 13.1%, guidance and SaaS momentum reaffirmed.SPNS
Q2 20242 Feb 2026 - Q3 revenue up 4.8%, ARR at $173M, but 2024 guidance trimmed amid SaaS transition.SPNS
Q3 202415 Jan 2026 - 2024 revenue and profit rose, with 2025 targets focused on AI, cloud, and recurring growth.SPNS
Q4 202417 Dec 2025 - Q1 2025 delivered revenue growth, strong ARR, and acquisitions, with raised full-year guidance.SPNS
Q1 202519 Nov 2025